Your browser doesn't support javascript.
loading
Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine.
Maron, Jenny S; Conroy, Michelle; Naranbai, Vivek; Samarakoon, Upeka; Motazedi, Tina; Farmer, Jocelyn R; Freeman, Esther; Banerji, Aleena; Bartsch, Yannic C; Gregory, David J; Poznansky, Mark C; Alter, Galit; Blumenthal, Kimberly G.
Afiliação
  • Maron JS; Ragon Institute, Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA.
  • Conroy M; Harvard Medical School, Boston, Massachusetts, USA.
  • Naranbai V; Harvard Medical School, Boston, Massachusetts, USA.
  • Samarakoon U; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Motazedi T; Harvard Medical School, Boston, Massachusetts, USA.
  • Farmer JR; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.
  • Freeman E; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Banerji A; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Bartsch YC; Ragon Institute, Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts, USA.
  • Gregory DJ; Harvard Medical School, Boston, Massachusetts, USA.
  • Poznansky MC; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Alter G; Harvard Medical School, Boston, Massachusetts, USA.
  • Blumenthal KG; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
J Infect Dis ; 226(7): 1231-1236, 2022 09 28.
Article em En | MEDLINE | ID: mdl-35325158

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Hipersensibilidade Limite: Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Hipersensibilidade Limite: Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos